PLD
45
-3
CVS
32
-9
GOOG
59
-22
MET
58
-2
BLK
58
-2
LYB
11
-2
UHS
62
-2
NSC
60
-2
FDX
51
-7
AAP
33
-3
TXN
53
-15
RL
76
-7
FLR
42
-3
ADSK
62
-4
LLY
62
-2
ISRG
69
-2
CHRW
71
-5
HON
63
3
VFC
72
-7
TDC
83
3
PLD
45
-3
CVS
32
-9
GOOG
59
-22
MET
58
-2
BLK
58
-2
LYB
11
-2
UHS
62
-2
NSC
60
-2
FDX
51
-7
AAP
33
-3
TXN
53
-15
RL
76
-7
FLR
42
-3
ADSK
62
-4
LLY
62
-2
ISRG
69
-2
CHRW
71
-5
HON
63
3
VFC
72
-7
TDC
83
3
Financhill
Back

JPMorgan US Tech Leaders ETF Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
58

JTEK
JPMorgan US Tech Leaders ETF

Last Price:
$92.63
Seasonality Move:
8.72%
Buy
90

KYMR
Kymera Therapeutics, Inc.

Last Price:
$94.38
Seasonality Move:
7.7%
Buy
58
JPMorgan US Tech Leaders ETF (JTEK) is a Buy

Is JPMorgan US Tech Leaders ETF a Buy, Sell or Hold?

  • The current JPMorgan US Tech Leaders ETF [JTEK] share price is $92.66. The Score for JTEK is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • JTEK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
90
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

JTEK Stock Price Chart

What is JPMorgan US Tech Leaders ETF's stock price today?

  • The JPMorgan US Tech Leaders ETF share price today is $92.66
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JTEK is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $94.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

JTEK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 56.13 Buy
Chaikin Money Flow: 77985 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.76 - 93.8) Buy
Bollinger Bands (100): (85.34 - 93.36) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 86.88 Buy
Chaikin Money Flow: -462379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.8 - 71.72) Buy
Bollinger Bands (100): (43.38 - 63.26) Buy

JTEK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.44 Buy
20-day SMA: 89.97 Buy
50-day SMA: 92.11 Buy
200-day SMA: 81.89 Buy
8-day EMA: 91.33 Buy
20-day EMA: 90.86 Buy
50-day EMA: 88.77 Buy
200-day EMA: 54.31 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70 Buy
20-day SMA: 66.61 Buy
50-day SMA: 61.97 Buy
200-day SMA: 44.25 Buy
8-day EMA: 72.36 Buy
20-day EMA: 67.57 Buy
50-day EMA: 61.93 Buy
200-day EMA: 49.42 Buy

JPMorgan US Tech Leaders ETF Earnings Growth & JTEK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

JPMorgan US Tech Leaders ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):